Max Stewart
About Max Stewart
Max Stewart is the Associate Director of R&D Integration & Program Management at Alkermes, with extensive experience in managing biopharmaceutical projects and a strong background in life sciences.
Current Role at Alkermes
Max Stewart is currently the Associate Director for R&D Integration & Program Management at Alkermes. Since October 2021, he has been leading initiatives to integrate research and development efforts. His role involves aligning project goals with organizational strategies to ensure timely and budget-conscious delivery of therapeutics.
Previous Work Experience
Max Stewart has held a series of managerial roles in the biopharmaceutical industry. He served as Associate Director, Program Management at Finch Therapeutics Group for a year in Somerville, MA from 2020 to 2021. Prior to that, he was a Project Manager at Sage Therapeutics for six months in Cambridge, MA, where he was involved in clinical development. From 2016 to 2019, he worked at Sarepta Therapeutics as a Project Manager in Translational Sciences. Stewart also has experience in government and healthcare, having worked for the U.S. Department of Veterans Affairs as a Health Scientist in R&D and at Mass General Brigham as a Senior Project Manager.
Educational Background
Max Stewart holds a Master of Business Administration (MBA) from the Questrom School of Business at Boston University, where he specialized in Health Sector Management from 2020 to 2022. He also earned a Bachelor of Science (BS) degree in Cognitive Science from the University of Massachusetts Boston, completing his studies between 2007 and 2011. His academic background lays a strong foundation for his career in managing complex projects in the biopharmaceutical sector.
Expertise in Program Management
With extensive experience in managing diverse portfolios of projects, Max Stewart specializes in the delivery of safe and effective therapeutics within the constraints of time, budget, and scope. He is known for his ability to drive cross-functional teams towards ambitious goals in fast-paced, rapidly changing environments. His skill set is particularly strong in pre-clinical and commercial stage life science settings.